Safety, tolerability, and risks associated with first-and second-generation antipsychotics: a state-of-the-art clinical review

M Solmi, A Murru, I Pacchiarotti… - … and clinical risk …, 2017 - Taylor & Francis
Since the discovery of chlorpromazine (CPZ) in 1952, first-generation antipsychotics (FGAs)
have revolutionized psychiatric care in terms of facilitating discharge from hospital and …

[KNJIGA][B] The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia

American Psychiatric Association - 2020 - psychiatryonline.org
The goal of this guideline is to improve the quality of care and treatment outcomes for
patients with schizophrenia, as defined by the Diagnostic and Statistical Manual of Mental …

Decreased pain sensitivity among people with schizophrenia: a meta-analysis of experimental pain induction studies

B Stubbs, T Thompson, S Acaster, D Vancampfort… - Pain, 2015 - journals.lww.com
Patients with schizophrenia report reduced pain sensitivity in clinical studies, but
experimental studies are required to establish pain sensitivity as a potential endophenotype …

Physical therapy and mental health: a sco** review

SE Heywood, J Connaughton, R Kinsella… - Physical …, 2022 - academic.oup.com
Objectives Coexistence of mental and physical health conditions is prevalent. To achieve
optimal physical therapy outcomes, neither should be treated in isolation. This review aimed …

The evidence for physical activity in the management of major mental illnesses: A concise overview to inform busy clinicians' practice and guide policy

G Ashdown-Franks, CM Sabiston… - Current opinion in …, 2019 - journals.lww.com
The quantity and quality of evidence regarding the efficacy of physical activity for mental
illnesses is increasing. Given the established and further potential benefits and low adverse …

Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care

S Moore, D Shiers, B Daly, AJ Mitchell… - Acta Psychiatrica …, 2015 - Wiley Online Library
Objective Acquiring a diagnosis of schizophrenia reduces life expectancy for many reasons
including poverty, difficulties in communication, side‐effects of medication and access to …

Bone mineral density in schizophrenia: an update of current meta-analysis and literature review under guideline of PRISMA

PT Tseng, YW Chen, PY Yeh, KY Tu, YS Cheng… - Medicine, 2015 - journals.lww.com
Medicine Log in or Register Get new issue alertsGet alerts Secondary Logo Journal Logo
Advanced Search Toggle navigation Register Login Articles & Issues Browse by Specialty …

Antipsychotic-induced bone loss: the role of dopamine, serotonin and adrenergic receptor signalling

DK Weerasinghe, JM Hodge, JA Pasco… - Frontiers in Cell and …, 2023 - frontiersin.org
Antipsychotics are commonly used in treating psychiatric disorders. These medications
primarily target dopamine the serotonin receptors, they have some affinity to adrenergic …

Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature …

M De Hert, J Detraux, B Stubbs - Expert Opinion on Drug Safety, 2016 - Taylor & Francis
Introduction: Using an antipsychotic medication can increase prolactin (PRL) levels, causing
hyperprolactinemia (HPRL). Although the occurrence of osteoporosis within the population …